FAKTOR OPTIONSSCHEIN - MERCK & CO. | Delayed Deutsche Boerse AG 17:30:51 03/06/2024 BST | ||
| 1.5 EUR | -12.28% |
|
| 1 month | +17.93% | ||
| 3 months | -6.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 1.5 | -12.28% |
| 31/05/24 | 1.71 | +13.25% |
| 30/05/24 | 1.51 | -9.58% |
| 29/05/24 | 1.67 | +1.21% |
| 28/05/24 | 1.65 | +18.71% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 05:30 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UL5A0E |
| ISIN | DE000UL5A0E6 |
| Date issued | 04/05/2023 |
| Strike | 146.5 $ |
| Maturity | Unlimited |
| Parity | 11.25 : 1 |
| Emission price | 4.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.67 € |
|---|---|
| Lowest since issue | 1.23 € |
| Spread | 0.05 € |
| Spread % | 3.23% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
